Steroid Efficacy on Audiologic Recovery in Patients With Sudden Sensorineural Hearing Loss and Vestibular Schwannoma: A Retrospective Review.

Abstract

OBJECTIVES:

The objectives of this study are to (i) estimate the incidence of vestibular schwannoma (VS) among patients in an integrated healthcare system who present for evaluation of sudden sensorineural hearing loss (SSNHL) and (ii) evaluate the efficacy of empiric steroid therapy on audiologic recovery among SSNHL patients ultimately diagnosed with VS.

METHODS:

A retrospective chart review was performed on patients presenting with SSNHL in 2021 at a multicenter integrated healthcare system serving over 4 million members. Patient demographics, audiometric data, VS diagnosis, therapeutic steroid intervention, and data regarding treatment response were recorded. A clinically significant audiometric improvement was defined as (i) an increase of 15% in word recognition score, (ii) a decrease of 15 dB in four-frequency pure-tone average (PTA) using frequencies of 500, 1000, 2000, and 4000 Hz, or (iii) a PTA of <20 dB on follow-up audiogram.

RESULTS:

Six hundred fifty-eight patients were reviewed, of which 309 (56.0% male; mean, 57.5 years) met the inclusion criteria with audiometric data and magnetic resonance imaging data. Ten patients (70.0% male; mean, 51.3 years) were found to have VS. Of these, five patients received oral steroid therapy alone, and five had combination therapy (oral + intratympanic steroid injections). No patients received intratympanic steroid therapy alone. Median PTA improvement with steroid therapy was 3.1-dB hearing loss, and median word recognition score improvement was 16.5%. Six of 10 patients demonstrated clinically significant audiometric improvement with steroid therapy.

CONCLUSION:

This study represents the largest US-based study showcasing the prevalence of VS in patients originally presenting with SSNHL. It also reinforces previous findings that VS does not preclude trials of steroid therapy.

• Authors: Pauline P Huynh, Elias S Saba, Jacob E Hoerter, Nancy Jiang
• Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (Otol Neurotol) Vol. 44 Issue 8 Pg. 780-785 (09 01 2023) ISSN: 1537-4505 [Electronic] United States
• PMID: 37464465 (Publication Type: Multicenter Study, Journal Article)
• Copyright: Copyright © 2023, Otology & Neurotology, Inc.

Chemical References

• Dexamethasone
• Steroids
• Glucocorticoids

Topics

• Humans
• Male
• Female
• Retrospective Studies
• Neuroma, Acoustic (complications, drug therapy)
• Dexamethasone
• Hearing Loss, Sudden (drug therapy, diagnosis)
• Hearing Loss, Sensorineural (drug therapy, etiology, diagnosis)
• Injection, Intratympanic
• Steroids (therapeutic use)
• Treatment Outcome
• Glucocorticoids
• Audiometry, Pure-Tone